4-[(methylsulfonyl)methyl]aniline(SALTDATA: FREE) → n5-[2-(4-Methanesulfonylmethyl-phenylamino)-pyrimidin-4-yl]-1,n5-dimethyl-n2-(1-phenyl-ethyl)-1h-benzoimidazole-2,5-diamine hydrochloride

HRID 1391588Notes

Reaction equation

[Cl:1][C:2]1[N:7]=[C:6]([N:8]([CH3:28])[C:9]2[CH:27]=[CH:26][C:12]3[N:13]([CH3:25])[C:14]([NH:16][CH:17]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)[CH3:18])=[N:15][C:11]=3[CH:10]=2)[CH:5]=[CH:4][N:3]=1.[CH3:29][S:30]([CH2:33][C:34]1[CH:40]=[CH:39][C:37]([NH2:38])=[CH:36][CH:35]=1)(=[O:32])=[O:31]>>[ClH:1].[CH3:29][S:30]([CH2:33][C:34]1[CH:40]=[CH:39][C:37]([NH:38][C:2]2[N:7]=[C:6]([N:8]([CH3:28])[C:9]3[CH:27]=[CH:26][C:12]4[N:13]([CH3:25])[C:14]([NH:16][CH:17]([C:19]5[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=5)[CH3:18])=[N:15][C:11]=4[CH:10]=3)[CH:5]=[CH:4][N:3]=2)=[CH:36][CH:35]=1)(=[O:31])=[O:32]

Participants

Reactant 2

HCID 128439644-[(methylsulfonyl)methyl]aniline(SALTDATA: FREE)

HCID 59674124N5-(2-Chloro-pyrimidin-4-yl)-1,N5-dimethyl-N2-(1-phenyl-ethyl)-1H-benzoimidazole-2,5-diamine

Product 1

HCID 10218577n5-[2-(4-Methanesulfonylmethyl-phenylamino)-pyrimidin-4-yl]-1,n5-dimethyl-n2-(1-phenyl-ethyl)-1h-benzoimidazole-2,5-diamine hydrochloride

Procedure

The title compound was prepared following the procedure of example two with N5-(2-Chloro-pyrimidin-4-yl)-1,N5-dimethyl-N2-(1-phenyl-ethyl)-1H-benzoimidazole-2,5-diamine (98 mg, 0.25 mmol) and 4-[(methylsulfonyl)methyl]aniline (46 mg, 0.25 mmol) as a white solid (66 mg, 46%). 1H NMR (400 MHz, d6-DMSO) δ 9.18 (s, 1H), 7.72-7.77 (M, 3H), 7.42 (d, J=7.6 Hz, 2H), 7.16-7.21 (m, 4H), 7.10 (d, J=8.0 Hz, 1H), 7.02 (d, J=2.0 Hz, 1H), 6.79 (dd, J=8.4 and 2.0 Hz, 1H), 5.58 (d, J=5.6 Hz, 1H), 5.12 (m, 1H), 4.31 (s, 2H), 3.58 (s, 3H), 3.38 (s, 3H), 2.82 (s, 3H), 1.50 (d, J=6.8 Hz, 3H). MS (ESI) m/z=542 [M+H]+.

Sources & evidence

ORD record: ord-88a4642d961a4704a5541c8292454216
Source dataset: uspto-grants-2008_03
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07338959B2

Reaction notes

Loading…